Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (1081-1090 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|October 31, 2020
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programmeStanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
RMD Open|September 30, 2020
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort studyJames Galloway, Kevin Barrett, Peter Irving, et al.
RMD Open|September 30, 2020
Cigarette smoking patterns preceding primary Sjögren's syndromeJohannes Mofors, Albin Björk, Elina Richardsdotter Andersson, et al.
RMD Open|January 8, 2020
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practiceNiels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, et al.
RMD Open|March 8, 2020
Escaping the catch 22 of lupus anticoagulant testingPernille Just Vinholt, Søren Andreas Just
RMD Open|January 21, 2020
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in uteroMalin Hedlund, Gudny Ella Thorlacius, Margarita Ivanchenko, et al.
RMD Open|January 21, 2020
Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspectiveGuillermo J Pons-Estel, Manuel Francisco Ugarte-Gil, Guillermina B Harvey, et al.
RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
RMD Open|January 6, 2022
Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysisRaphael Micheroli, Muriel Elhai, Sam Edalat, et al.
Pageof 192

Showing results (1081-1090 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|October 31, 2020
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programmeStanley B Cohen, Yoshiya Tanaka, Xavier Mariette, et al.
RMD Open|September 20, 2020
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaborationBrigitte Michelsen, Ulf Lindström, Catalin Codreanu, et al.
RMD Open|September 30, 2020
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort studyJames Galloway, Kevin Barrett, Peter Irving, et al.
RMD Open|September 30, 2020
Cigarette smoking patterns preceding primary Sjögren's syndromeJohannes Mofors, Albin Björk, Elina Richardsdotter Andersson, et al.
RMD Open|January 8, 2020
Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practiceNiels W Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, et al.
RMD Open|March 8, 2020
Escaping the catch 22 of lupus anticoagulant testingPernille Just Vinholt, Søren Andreas Just
RMD Open|January 21, 2020
Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in uteroMalin Hedlund, Gudny Ella Thorlacius, Margarita Ivanchenko, et al.
RMD Open|January 21, 2020
Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspectiveGuillermo J Pons-Estel, Manuel Francisco Ugarte-Gil, Guillermina B Harvey, et al.
RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.
RMD Open|January 6, 2022
Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysisRaphael Micheroli, Muriel Elhai, Sam Edalat, et al.
Pageof 192